Trulieve Cannabis Corp: 3 Reasons to Consider This Top Pot Stock Now


2021-08-25 22:00:17 PROFIT


Compared to the buying frenzy that pot stocks enjoyed earlier this year, the current market doesn’t seem very enthusiastic about the sector. However, that’s exactly why this could be the right time to check out some solid pot stocks. After all, it was Warren Buffett who famously said, “Be fearful when others are greedy and greedy when others are fearful.” So let’s take a look at one of the most solid pot stocks on the market: Trulieve Cannabis Corp (CNSX:TRUL, OTCMKTS:TCNNF). The first reason to consider TCNNF stock is the company’s leading position in the state of Florida. Trulieve won the first medical marijuana application in Florida in 2015, opened its first dispensary there in 2016, and won the ability to grandfather in 14 stores above the Florida cap in 2017. (Source: “Investor Presentation: June 2021,” Trulieve Cannabis Corp, last accessed August 24, 2021.) In 2018, the company went public on the Canadian Securities Exchange through a reverse takeover. It also made several acquisitions during that year. In 2019, Trulieve became the first company to sell smokable marijuana flower in Florida. It then went on to become the first company to sell edibles in the state. Today, Trulieve Cannabis Corp has more than 80 dispensaries in the Sunshine State, with a growing customer database of more than 567,000. The company estimates that it has a 48% share of the medical cannabis market in Florida. Other than being the most dominant player in Florida’s pot market, Trulieve has licenses in California, Massachusetts, Connecticut, Pennsylvania, West Virginia, and Georgia. The second reason to consider Trulieve stock is that the company has been growing rapidly. In 2020, the company’s revenue increased by 106% year-over-year to $521.5 million. (Source: “Trulieve Reports Fourth Quarter and Full-Year 2020 Results and Announces Full-Year 2021 Guidance,” Trulieve Cannabis Corp, March 23, 2021.) Its adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) also nearly doubled, from $126.4 million in 2019 to $251.0 million in 2020. That growth momentum has continued in 2021. In the first six months of this year, Trulieve generated $408.9 million of total revenue, marking another 89% increase year-over-year. (Source: “Trulieve Reports Record Second Quarter 2021 Earnings and Expansion into New Markets,” Trulieve Cannabis Corp, August 12, 2021.) Its adjusted EBITDA came in at $185.7 million during this period, up by 69% from a year earlier. Trulieve Cannabis Corp is profitable, which isn’t usually the case for most pot companies. 2020 marked Trulieve’s third straight year of profitability. And considering that the company’s net income of $71.0 million in the first six months of 2021 was 67% higher than what it earned in the year-ago period, it’s on track to deliver another year of strong bottom-line growth. As mentioned earlier, pot stocks aren’t exactly hot commodities at the moment. Looking at Trulieve Cannabis Corp, we see that its share price reached new highs in January, February, and March, but it wasn’t able to continue that momentum. In fact, the pullback was so strong that TCNNF stock is currently trading around 50% of where it was during its March peak. One consequence of this sell-off is that, based on its relative strength index (RSI), Trulieve stock is quite oversold. RSI is calculated based on the closing prices of a recent trading period and compares the magnitude of recent gains to recent losses in order to measure the momentum in a stock. It ranges from zero to 100. A stock is considered to be overbought once the RSI approaches 70 and oversold if the RSI approaches 30. As you can see from the top of the below chart, the 14-day RSI of TCNNF stock has fallen to 25.7, meaning it’s extremely oversold. Considering that RSI is an oscillator—meaning it moves between two extremes—we could see a bounce in Trulieve stock in the near future. Chart courtesy of As I always say, pot stocks are some of the most volatile tickers in the market, so beware of the risks before you make any decision about Trulieve Cannabis Corp. In the marijuana sector, share prices don’t move like those of companies like Procter & Gamble Co (NYSE:PG) or Coca-Cola Co (NYSE:KO). That said, for investors who understand the underlying risks with pot stocks, TCNNF stock could be one of the best plays in the field.
与今年早些时候大麻股的购买狂潮相比,目前市场似乎对该行业不太热情。 然而,这正是为什么这可能是检查一些坚实的锅股票的正确时机。毕竟,沃伦·巴菲特说过一句名言:“当别人贪婪时要恐惧,当别人恐惧时要贪婪。” 因此,让我们来看看市场上最可靠的大麻股票之一:Trulieve Cannabis Corp(CNSX:TRUL,OTCMKTS:TCNNF)。 考虑TCNNF股票的第一个原因是该公司在佛罗里达州的领导地位。 Trulieve于2015年在佛罗里达州赢得了第一个医用大麻申请,2016年在那里开设了第一个药房,并于2017年在佛罗里达州上限以上的14家商店赢得了祖父的能力。(来源:“投资者陈述:2021年6月”,Trulieve Cannabis Corp,最后一次访问是2021年8月24日。) 2018年,公司通过反向收购在加拿大证券交易所上市。在那一年里,它还进行了几次收购。 2019年,Trulieve成为佛罗里达州第一家销售可吸烟大麻花的公司。后来,它成为该州第一家销售食品的公司。 今天,Trulieve大麻公司在阳光州有80多家药房,客户数据库越来越多,超过567,000人。该公司估计,它拥有佛罗里达州医用大麻市场48%的份额。 Trulieve除了是佛罗里达州大麻市场最具主导地位的参与者之外,还在加利福尼亚州、马萨诸塞州、康涅狄格州、宾夕法尼亚州、西弗吉尼亚州和佐治亚州拥有许可证。 考虑Trulieve股票的第二个原因是该公司一直在快速增长。 2020年,公司营收同比增长106%至5.215亿美元。(来源:“Trulieve报告2020年第四季度和全年业绩并宣布2021年全年指导意见”Trulieve大麻公司,2021年3月23日。) 其调整后的利息、税项、折旧和摊销前利润(EBITDA)也几乎翻了一番,从2019年的1.264亿美元增加到2020年的2.51亿美元。 这种增长势头在2021年继续保持。今年前六个月,Trulieve的总收入为4.089亿美元,同比增长89%。(来源:“Trulieve报告创纪录的2021年第二季度收益和向新市场的扩张”Trulieve大麻公司,2021年8月12日。) 在此期间,其调整后的EBITDA为1.857亿美元,较上年同期增长69%。 Trulieve大麻公司是盈利的,但大多数大麻公司通常不是这样。2020年标志着Trulieve连续第三年盈利。 考虑到该公司2021年前六个月7100万美元的净收入比去年同期高67%,它有望实现又一年的强劲底线增长。 如前所述,大麻目前并不是热门商品。 看看Trulieve Cannabis Corp,我们看到它的股价在1月、2月和3月创下新高,但它无法继续这种势头。 事实上,回调如此强劲,以至于TCNNF股票目前的交易量约为3月份峰值时的50%。 这次抛售的一个后果是,根据其相对强弱指数(RSI),Trulieve的股票相当超卖。 RSI是根据最近交易期间的收盘价计算的,并将最近的收益和损失的幅度进行比较,以衡量股票的动量。范围从零到100。一旦RSI接近70,股票被认为是超买,如果RSI接近30,股票被认为是超卖。 你可以从下面图表的顶部看到,TCNNF股票的14天RSI已经跌到25.7,这意味着它极度超卖。考虑到RSI是一个振荡器--意味着它在两个极端之间移动--我们可以看到Trulieve股票在不久的将来反弹。 图表由stockcharts.com提供 正如我常说的,大麻股票是市场上波动最大的股票,所以在你对Trulieve Cannabis Corp.做出任何决定之前,要小心风险。在大麻行业,股价不像宝洁公司(NYSE:PG)或可口可乐公司(NYSE:KO)这样的公司。 也就是说,对于理解pot股票潜在风险的投资者来说,TCNNF股票可能是该领域最好的选择之一。